Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cytune Pharma

Cytune Pharma?uq=AFYHfsyn
2007 FOUNDED
M&A STATUS
Buyout/LBO LATEST DEAL TYPE
5 FINANCING ROUNDS
Description

Developer of immunotherapeutic agents. The company specializes in the in research and development of immunotherapies, whose properties allow the restoration and stimulation of immune functions of patients suffering from serious pathologies, in particular cancerous.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Acquirer
Primary Office
  • 7 Rue Amédée Ménard
  • 44300 Nantes
  • France

Cytune Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Cytune Pharma‘s full profile, request access.

Request full access to PitchBook

Cytune Pharma Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Cytune Pharma‘s full profile, request access.

Request full access to PitchBook

Cytune Pharma Executive Team (5)

Name Title Board
Seat
Contact
Info
David Béchard Ph.D Co-Founder, President, Chief Executive Officer & Chief Operating Officer
Gaëtan Decherf Ph.D Chief Financial Officer & Full-time Project Manager
Guy De Martynoff Ph.D Chief Technology Officer
Yannick Jacques Ph.D Co-Founder & Chief Scientific Officer
Didier Coquoz Ph.D Chief Development and Business Development Officer